Eurofins Scientific SE (FRA:ESF0) EBIT: €811 Mil (TTM As of Dec. 2025)


FRA:ESF0 Eurofins Scientific SE FRA:ESF0
87 GF Score
Price €64.88
GF Value €66.54
Valuation Fairly Valued
! 6 Warning Signs
View Full Analysis

What is Eurofins Scientific SE EBIT?

Eurofins Scientific SE FRA:ESF0 +3.31% 87 EBIT is €811 Mil as of Dec. 2025. GuruFocus rates FRA:ESF0 with a GF Score™ of 87/100 and a GF Value™ of €66.54 (Fairly Valued). The stock has 6 warning signs investors should review.

Eurofins Scientific SE's earnings before interest and taxes (EBIT) for the six months ended in Dec. 2025 was €394 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Dec. 2025 was €811 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Eurofins Scientific SE's annualized ROC % for the quarter that ended in Dec. 2025 was 6.50%. Eurofins Scientific SE's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2025 was 30.28%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Eurofins Scientific SE's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2025 was 5.42%.

Eurofins Scientific SE  (FRA:ESF0) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Eurofins Scientific SE's annualized ROC % for the quarter that ended in Dec. 2025 is calculated as:

ROC % (Q: Dec. 2025 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Jun. 2025 ) + Invested Capital (Q: Dec. 2025 ))/ count )
=820.8 * ( 1 - 26.44% )/( (9279.2 + 9303.2)/ 2 )
=603.78048/9291.2
=6.50 %

where

Invested Capital(Q: Jun. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=10585.9 - 773.3 - ( 753.3 - max(0, 2085.4 - 2618.8+753.3))
=9279.2

Invested Capital(Q: Dec. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=10985.4 - 1458.3 - ( 791.2 - max(0, 2429.6 - 2653.5+791.2))
=9303.2

Note: The Operating Income data used here is two times the semi-annual (Dec. 2025) data.

2. Joel Greenblatt's definition of Return on Capital:

Eurofins Scientific SE's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2025 is calculated as:

ROC (Joel Greenblatt) %(Q: Dec. 2025 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Jun. 2025  Q: Dec. 2025
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=787.4/( ( (2437.4 + max(-9.3, 0)) + (2762.9 + max(-271.3, 0)) )/ 2 )
=787.4/( ( 2437.4 + 2762.9 )/ 2 )
=787.4/2600.15
=30.28 %

where Working Capital is:

Working Capital(Q: Jun. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(1069.5 + 145.9 + 322.3) - (773.3 + 0 + 773.7)
=-9.3

Working Capital(Q: Dec. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(1096.9 + 139.3 + 195.4) - (1458.3 + 0 + 244.6)
=-271.3

When net working capital is negative, 0 is used.

Note: The EBIT data used here is two times the semi-annual (Dec. 2025) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Eurofins Scientific SE's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Dec. 2025 )
=811.2/14974.963
=5.42 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Eurofins Scientific SE EBIT Related Terms

Eurofins Scientific SE EBIT Historical Data

* Premium members only.

The historical data trend for Eurofins Scientific SE's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Eurofins Scientific SE EBIT Chart

Eurofins Scientific SE Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,151.60 885.60 552.70 705.40 811.20

Eurofins Scientific SE Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 274.20 377.20 328.20 417.50 393.70

FRA:ESF0 vs TMO, DHR, IDXX: EBIT Comparison

For the Diagnostics & Research subindustry, Eurofins Scientific SE's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Eurofins Scientific SE EV-to-EBIT vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Eurofins Scientific SE's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Eurofins Scientific SE's EV-to-EBIT falls into.


FRA:ESF0
87GF Score
Eurofins Scientific SE FRA:ESF0
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Eurofins Scientific SE EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was €811 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of €811 Mil mean?
Eurofins Scientific SE (FRA:ESF0) has a EBIT of €811 Mil as of Dec. 2025. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Eurofins Scientific SE.
Is Eurofins Scientific SE's EBIT too high?
Eurofins Scientific SE's current EBIT is €811 Mil. Overall, Eurofins Scientific SE has a GF Score™ of 87/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Eurofins Scientific SE's EBIT compare to TMO and DHR?
Eurofins Scientific SE's EBIT of €811 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Medical Diagnostics & Research company?
A good EBIT depends on the Medical Diagnostics & Research industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Eurofins Scientific SE. Eurofins Scientific SE's current EBIT is €811 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Eurofins Scientific SE stock overvalued right now?
Based on GuruFocus' analysis, Eurofins Scientific SE (FRA:ESF0) is currently considered Fairly Valued. The stock's GF Value™ is €66.54, compared to a current price of €64.88 — trading 2.5% below its estimated fair value. The current EBIT is €811 Mil. Eurofins Scientific SE's overall GF Score™ is 87/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For Eurofins Scientific SE (FRA:ESF0), the current EBIT is €811 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Eurofins Scientific SE (FRA:ESF0) Overvalued in 2026?

Based on GuruFocus' analysis, Eurofins Scientific SE stock appears to be undervalued. The current stock price of €64.88 is trading 2.5% below its estimated GF Value™ of €66.54. GuruFocus considers Eurofins Scientific SE to be Fairly Valued.

Key valuation signals for FRA:ESF0:

  • EBIT: €811 Mil
  • GF Value™: €66.54 vs. price of €64.88 (2.5% below fair value)
  • GF Score™: 87/100 with 6 warning signs

No single metric tells the full story. See the FRA:ESF0 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Eurofins Scientific SE Business Description

Address 23 Val Fleuri, Luxembourg, LUX, 1526
Eurofins, headquartered in Luxembourg, is a decentralized network of life sciences companies that provide various analytical tests and laboratory services. These include tests to evaluate the safety, identity, composition, authenticity, purity, origin, and traceability of various biological substances and products. Eurofins operates over 950 laboratories in 61 countries. Its revenue from Europe, North America, and the rest of the world contributes approximately 50%, 40%, and 10% of total revenue, respectively. Its areas of business activity are food, feed, and environmental testing ("life"), biopharmaceutical services, diagnostic services and products, and consumer and technology products testing, which contribute approximately 40%, 30%, 20%, and 10% respectively.
87GF Score

Get the complete analysis for FRA:ESF0

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€64.88
Price
€66.54
GF Value